These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8557007)

  • 1. Research and development of aminosteroid neuromuscular blocking agents: past and future.
    Marshall RJ; Muir AW; Sleigh T; Savage DS
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():5-10. PubMed ID: 8557007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sugammadex: another milestone in clinical neuromuscular pharmacology.
    Naguib M
    Anesth Analg; 2007 Mar; 104(3):575-81. PubMed ID: 17312211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of SZ1677, a new non-depolarizing steroidal neuromuscular blocking drug, and rocuronium on two laryngeal muscles and the anterior tibial muscle in guinea pigs.
    Michalek-Sauberer A; Nicolakis EM; Vizi ES; Gilly H
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):481-7. PubMed ID: 16548861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postsynaptic nondepolarizing muscle relaxants in clinical practice].
    Danilov AF
    Eksp Klin Farmakol; 1998; 61(3):74-80. PubMed ID: 9690085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acid base changes and muscle relaxants].
    Ono K; Ohta Y; Nagano O; Aziz L; Hirakawa M
    Masui; 1996 Jan; 45(1):2-14. PubMed ID: 8865718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor.
    Jonsson Fagerlund M; Dabrowski M; Eriksson LI
    Anesthesiology; 2009 Jun; 110(6):1244-52. PubMed ID: 19417616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-pharmacodynamic-pharmacokinetic relationships of steroidal neuromuscular blocking agents.
    Wierda JM; Proost JH
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():45-54. PubMed ID: 8557006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroidal muscle relaxants attenuate the contractile and phosphatidylinositol responses of rat trachea.
    Hashimoto S; Shibata O; Tsuda A; Iwanaga S; Makita T; Sumikawa K
    Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):255-63. PubMed ID: 9730005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of sugammadex.
    Caldwell JE; Miller RD
    Anaesthesia; 2009 Mar; 64 Suppl 1():66-72. PubMed ID: 19222433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mivacurium.
    Feldman S
    Br J Hosp Med; 1997 Mar 5-18; 57(5):199-201. PubMed ID: 9176596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the ability for conformational changes and the specificity of non-depolarizing muscle relaxants.
    Danilov AF; Fedorov DY; Shelkovnikov SA; Starshinova LA
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):133-8. PubMed ID: 6214923
    [No Abstract]   [Full Text] [Related]  

  • 14. The importance of myorelaxants in anesthesia.
    Flood P
    Curr Opin Pharmacol; 2005 Jun; 5(3):322-7. PubMed ID: 15907920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in neuromuscular blocking agents.
    Zlotos DP
    Mini Rev Med Chem; 2005 Jun; 5(6):595-606. PubMed ID: 15974937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of muscle relaxants for routine induction of anesthesia in Germany].
    Geldner G; Fuchs-Buder T; Hofmockel R; Diefenbach C; Ulm K; Blobner M
    Anaesthesist; 2003 May; 52(5):435-41. PubMed ID: 12750828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
    Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
    Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
    Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The future directions in the search for postsynaptic muscle relaxants with rapidly developing and short-term action].
    Danilov AF
    Eksp Klin Farmakol; 1993; 56(4):3-6. PubMed ID: 8220010
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of ultra short-acting muscle relaxant agents: history, research strategies, and challenges.
    Gyermek L
    Med Res Rev; 2005 Nov; 25(6):610-54. PubMed ID: 16086361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.